The article has been automatically translated into English by Google Translate from Russian and has not been edited.
Переклад цього матеріалу українською мовою з російської було автоматично здійснено сервісом Google Translate, без подальшого редагування тексту.
Bu məqalə Google Translate servisi vasitəsi ilə avtomatik olaraq rus dilindən azərbaycan dilinə tərcümə olunmuşdur. Bundan sonra mətn redaktə edilməmişdir.

Pfizer announced its readiness to vaccinate against COVID-19 children from 5 years old: the US authorities promise to quickly approve the request

Pfizer-BioNTech said low doses of COVID-19 vaccine are safe and effective for children 5-11 years old. USA Today.

Photo: Shutterstock

Pfizer-BioNTech's COVID-19 vaccine is safe and effective for children aged 5 to 11, according to a new company study. Children should be given one third of the dose used for adolescents and adults.

Many parents were looking forward to the vaccines for their children who returned to school. Due to the delta strain of coronavirus, the incidence of COVID-19 among children has jumped by about 240% since July.

Children are less likely to become seriously ill with COVID-19 than adults, but they can contract and transmit the virus and sometimes suffer from serious illnesses with long-term consequences.

You may be interested in: top New York news, stories of our immigrants and helpful tips about life in the Big Apple - read it all on ForumDaily New York.

The FDA and the Centers for Disease Control and Prevention will need to approve the vaccine before it becomes available to children, but government officials have promised to quickly review the data.

The authorization is likely to be issued within "a few weeks, not months," said Dr. Peter Marks of the FDA.

“The FDA is committed to addressing these issues as quickly as possible,” he added.

The Pfizer-BioNTech vaccine is currently fully approved for use in older adults and adolescents, although it is still only approved for emergency use in children 12 to 15 years of age.

“We are committed to extending the protection provided by the vaccine to this younger segment of the population, subject to regulatory approval, especially as we monitor the spread of the delta variant and the significant threat it poses to children,” said Albert Burla. Chairman and CEO of Pfizer. “These test results provide a solid basis for obtaining approval to administer our vaccine to children aged 5 to 11 years. And we plan to urgently submit this data to the FDA and other regulatory bodies. "

On the subject: The United States will lift the ban on international travel and will again accept tourists from all countries

The Pfizer-BioNTech vaccine dose for adults is 30 micrograms, while the company offers a 10 microgram dose for children ages 5-11. As with adults, the vaccine will be given to children in two shots at least three weeks apart.

At this lower dose, the vaccine is safe for children and results in the same mostly minor side effects seen in adolescents and young adults, according to new research.

A study of 2 volunteers aged 268 to 5 years showed that they developed the same strong immune response to the vaccine as and in adolescents and young adults. Since Pfizer's vaccine has already proven its effectiveness in older groups, the company only needed to show that the vaccine is safe and induce a similar immune response in children, rather than prove again that it prevents COVID-19 disease.

The company is also investigating the use of the vaccine for children ages 2 to 5 and 6 months to 2 years of age, but these trials have not yet been completed. Young children are given 3 micrograms of the vaccine.

Participants in all three trials come from more than 90 regions in the United States, Finland, Poland and Spain, the companies say.

Two other companies licensed for COVID-19 vaccines in the United States, Moderna and Johnson & Johnson, are also exploring their child protection drugs, but have yet to complete their studies.

Read also on ForumDaily:

Flu vaccine during the COVID-19 pandemic: do or not

Reduces the concentration of the virus: a cheap drug for cholesterol cures for COVID-19

How long does immunity last after vaccination against COVID-19: data on different drugs

Miscellaneous In the U.S. Pfizer Vaccination of children against COVID-19 new research small dose
Subscribe to ForumDaily on Google News

Let's face the crisis together and support each other

Thank you for staying with us and trusting! Over the past 5 years, we have received a lot of grateful feedback from readers, whom our materials have helped to arrange life after moving to the United States. We have big plans, we do not want to stop or slow down the pace of work. Even now…

The COVID-19 pandemic has negatively affected our income, and in order to stay afloat, we have to ask YOU for support. We will be grateful for any amount and will make every effort to continue to publish news and a lot of useful information just as quickly.

Thank you for being with us!

Always yours, ForumDaily!

Security of contributions is guaranteed by the use of the highly secure Stripe system.

Do you want more important and interesting news about life in the USA and immigration to America? Subscribe to our page in Facebook. Choose the "Display Priority" option and read us first. Also, don't forget to subscribe to our РєР ° РЅР ° Р »РІ Telegram - there are many interesting things. And join thousands of readers ForumDaily Woman и ForumDaily New York - there you will find a lot of interesting and positive information. 

1088 requests in 2,254 seconds.